Our understanding of dry eye is evolving. Discover the latest findings – including a first look discussion of DEWS III guidelines – at a
Following a sellout success in 2024, the Australian College of Optometry (ACO) has announced the return of its Paediatric Masterclass and Anterior Segment Workshop
Novartis has announced positive top-line results from its Phase III trials – NEPTUNUS-1 and NEPTUNUS-2 – evaluating ianalumab (VAY736) in adults with active Sjögren’s
At a time when artificial intelligence (AI) is promising to revolutionise medical practice and transform patient outcomes, the Australian Medical Association is calling for
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
